| 000 | 01245 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515024709.0 | ||
| 264 | 0 | _c20061109 | |
| 008 | 200611s 0 0 eng d | ||
| 022 | _a1469-0756 | ||
| 024 | 7 |
_a10.1136/pgmj.2005.041533 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhan, S | |
| 245 | 0 | 0 |
_aUse of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis. _h[electronic resource] |
| 260 |
_bPostgraduate medical journal _cMay 2006 |
||
| 300 |
_a353-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aDermatologic Agents _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedical Audit |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
| 650 | 0 | 4 |
_aProcollagen _xmetabolism |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 700 | 1 | _aSubedi, D | |
| 700 | 1 | _aChowdhury, M M U | |
| 773 | 0 |
_tPostgraduate medical journal _gvol. 82 _gno. 967 _gp. 353-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/pgmj.2005.041533 _zAvailable from publisher's website |
| 999 |
_c16280467 _d16280467 |
||